DS-6051b
Phase 1Completed 0 views this week 0 watching💤 Quiet
Interest: 29/100
29
Development Stage
✓
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Advanced Solid Malignant Tumors
Conditions
Advanced Solid Malignant Tumors
Trial Timeline
Feb 10, 2016 → Dec 28, 2021
NCT ID
NCT02675491About DS-6051b
DS-6051b is a phase 1 stage product being developed by Daiichi Sankyo for Advanced Solid Malignant Tumors. The current trial status is completed. This product is registered under clinical trial identifier NCT02675491. Target conditions include Advanced Solid Malignant Tumors.
What happened to similar drugs?
16 of 20 similar drugs in Advanced Solid Malignant Tumors were approved
Approved (16) Terminated (1) Active (4)
Hype Score Breakdown
Clinical
6
Activity
8
Company
15
Novelty
0
Community
0
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT02675491 | Phase 1 | Completed |
Competing Products
20 competing products in Advanced Solid Malignant Tumors